Clinical Trials Browser

Biliary Tract Adenocarcinoma × donafenib × Clear all

NCT05350943 2022-10-18

HAIC Combined With Toripalimab and Donafenib for Advanced BTC

Phase 2 Unknown

Gastrointestinal

Biliary Tract Adenocarcinoma